
  
    
      
        Background_NNP
        Differentiation_NNP is_VBZ commonly_RB associated_VBN with_IN intermingled_JJ
        changes_NNS in_IN gene_NN expression_NN and_CC cellular_JJ proliferation_NN ._. In_IN
        some_DT differentiating_VBG cell_NN types_NNS ,_, changes_NNS in_IN both_DT gene_NN
        transcription_NN and_CC proliferation_NN are_VBP regulated_VBN by_IN the_DT same_JJ
        transcription_NN factor_NN [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD ]_NN ._. CCAAT_NNP /_NN Enhancer_NNP
        Binding_NNP Protein_NNP alpha_NN (_( C_NNP /_NN EBPα_NNP )_) is_VBZ a_DT transcription_NN factor_NN
        that_WDT is_VBZ required_VBN for_IN the_DT differentiation_NN of_IN a_DT number_NN of_IN
        tissues_NNS [_NN 10_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD 17_CD 18_CD ]_NN ._. Mice_NNS homozygous_JJ
        for_IN C_NNP /_NN EBPα_NNP null_NN alleles_NNS have_VBP severe_JJ defects_NNS in_IN tissues_NNS
        involved_VBN in_IN metabolic_JJ homeostasis_NNS [_NN 19_CD 20_CD 21_CD ]_NN ._. Cellular_NNP
        proliferation_NN is_VBZ elevated_VBD in_IN the_DT liver_NN of_IN these_DT knockout_NN
        mice_NNS [_NN 22_CD ]_NN suggesting_VBG that_IN C_NNP /_NN EBPα_NNP blocks_NNS proliferation_NN 
        in_IN vivo_NN ._. In_IN cultured_JJ cells_NNS ,_, C_NNP /_NN EBPα_NNP
        expression_NN leads_VBZ to_TO decreased_VBN colony_NN formation_NN upon_IN
        antibiotic_JJ selection_NN [_NN 23_CD 24_CD 25_CD ]_NN ,_, decreased_VBD DNA_NNP synthesis_NN
        [_NN 22_CD 24_CD 25_CD 26_CD 27_CD ]_NN and_CC an_DT enhanced_JJ proportion_NN of_IN cells_NNS in_IN
        the_DT G_NNP 1_CD phase_NN of_IN the_DT cell_NN cycle_NN [_NN 26_CD ]_NN ._. Thus_RB ,_, C_NNP /_NN EBPα_NNP
        regulates_VBZ cellular_JJ proliferation_NN ,_, as_RB well_RB as_IN gene_NN
        transcription_NN ._.
        C_NNP /_NN EBPα_NNP contains_VBZ a_DT bZIP_NN domain_NN conserved_JJ at_IN the_DT carboxy_NN
        terminus_JJ of_IN a_DT number_NN of_IN transcription_NN factors_NNS [_NN 12_CD 28_CD ]_NN ._.
        The_DT bZIP_NN domain_NN consists_VBZ of_IN a_DT basic_JJ region_NN that_IN binds_NNS
        directly_RB to_TO DNA_NNP ,_, followed_VBD immediately_RB by_IN a_DT leucine_NN zipper_NN ._.
        C_NNP /_NN EBPα_NNP dimerizes_NNS via_IN the_DT leucine_NN zipper_NN ._. This_DT dimerization_NN
        is_VBZ required_VBN for_IN DNA_NNP binding_JJ [_NN 28_CD 29_CD ]_NN ._. At_IN least_JJS three_CD
        transcription_NN activation_NN functions_NNS have_VBP been_VBN described_VBN in_IN
        the_DT more_RBR amino_JJ terminal_NN regions_NNS of_IN C_NNP /_NN EBPα_NNP [_NN 30_CD 31_CD 32_CD ]_NN ._.
        C_NNP /_NN EBPα_NNP domains_NNS and_CC activities_NNS associated_VBN with_IN proliferation_NN
        arrest_NN also_RB have_VBP been_VBN identified_VBN ,_, but_CC vary_VBP considerably_RB
        between_IN studies_NNS [_NN 23_CD 25_CD 33_CD 34_CD 35_CD 36_CD ]_NN ._.
        C_NNP /_NN EBPα_NNP binds_NNS to_TO and_CC activates_NNS transcription_NN of_IN the_DT gene_NN
        promoter_NN for_IN the_DT p_NN 21_CD inhibitor_NN of_IN cyclin-dependent_JJ kinase_NN
        (_( CDK_NNP )_) [_NN 37_CD ]_NN ._. This_DT led_VBN to_TO speculation_NN that_DT p_NN 21_CD gene_NN
        activation_NN may_MD contribute_VB to_TO cell_NN cycle_NN arrest_NN by_IN C_NNP /_NN EBPα_NNP [_NN
        37_CD ]_NN ._. Similarly_RB ,_, suppression_NN of_IN mitotic_JJ growth_NN during_IN
        adipocyte_NN differentiation_NN was_VBD associated_VBN with_IN C_NNP /_NN EBPα_NNP
        activation_NN of_IN the_DT promoters_NNS of_IN gadd_NN 45_CD (_( growth_NN arrest_NN and_CC
        DNA_NNP damage-inducible_JJ gene_NN 45_CD )_) ,_, gas_NN 2_CD and_CC gas_NN 3_CD (_( growth_NN
        arrest-associated_JJ genes_NNS 2_CD and_CC 3_LS )_) [_NN 5_CD 6_CD 38_CD 39_CD ]_NN ._. However_RB ,_,
        C_NNP /_NN EBPα_NNP mutants_NNS defective_JJ in_IN DNA_NNP binding_JJ still_RB blocked_VBN
        proliferation_NN [_NN 25_CD 33_CD ]_NN ._. This_DT suggested_VBD that_IN direct_JJ
        promoter_NN activation_NN was_VBD unnecessary_JJ ,_, or_CC redundant_JJ ,_, for_IN
        C_NNP /_NN EBPα_NNP proliferation_NN arrest_NN [_NN 18_CD ]_NN ._.
        Possible_JJ mechanisms_NNS of_IN transcription-independent_JJ
        proliferation_NN arrest_NN by_IN C_NNP /_NN EBPα_NNP have_VBP been_VBN suggested_VBN by_IN a_DT
        number_NN of_IN studies_NNS ._. Decreased_NNP proliferation_NN was_VBD associated_VBN
        with_IN C_NNP /_NN EBPα_NNP stabilization_NN of_IN the_DT p_NN 21_CD protein_NN [_NN 22_CD 24_CD ]_NN ._.
        p_NN 21_CD interacted_JJ directly_RB with_IN a_DT large_JJ internal_JJ segment_NN of_IN
        C_NNP /_NN EBPα_NNP that_WDT included_JJ transcription_NN activation_NN domain_NN 3_CD [_NN 25_CD
        ]_NN (_( see_VB Fig_NNP ._. 1_LS A_DT )_) ._. CDK_NNP 2_CD and_CC CDK_NNP 4_CD also_RB interacted_JJ with_IN
        segments_NNS of_IN C_NNP /_NN EBPα_NNP close_VBP to_TO ,_, and_CC within_IN ,_, transcription_NN
        activation_NN domain_NN 3_CD [_NN 36_CD ]_NN ._. CDK_NNP 2_CD also_RB interacted_JJ with_IN the_DT
        basic_JJ region_NN of_IN the_DT C_NNP /_NN EBPα_NNP [_NN 25_CD ]_NN ._. p_NN 21_CD also_RB has_VBZ a_DT second_JJ
        interaction_NN site_NN ,_, within_IN the_DT leucine_NN zipper_NN of_IN C_NNP /_NN EBPα_NNP [_NN 25_CD
        ]_NN ._. 
        in_IN vitro_NN ,_, C_NNP /_NN EBPα_NNP enhanced_JJ p_NN 21_CD
        inhibition_NN of_IN CDK_NNP 2_CD activity_NN ._. C_NNP /_NN EBPα_NNP inhibition_NN of_IN CDK_NNP 2_CD
        activity_NN correlated_JJ with_IN p_NN 21_CD binding_JJ to_TO C_NNP /_NN EBPα_NNP
        transcription_NN activation_NN domain_NN 3_CD [_NN 25_CD ]_NN ._. However_RB ,_,
        proliferation_NN arrest_NN by_IN C_NNP /_NN EBPα_NNP still_RB occurred_VBD in_IN cell_NN lines_NNS
        not_RB containing_VBG p_NN 21_CD genes_NNS [_NN 40_CD ]_NN ._. This_DT indicated_VBD that_DT
        proliferation_NN arrest_NN by_IN C_NNP /_NN EBPα_NNP did_VBD not_RB rely_VB solely_RB upon_IN
        C_NNP /_NN EBPα_NNP enhancement_NN of_IN CDK_NNP inhibition_NN by_IN p_NN 21_CD ._.
        Another_DT mechanism_NN reported_VBD for_IN proliferation_NN blockage_NN by_IN
        C_NNP /_NN EBPα_NNP involves_VBZ the_DT E_NNP 2_CD F-DP_NNP 1_CD transcription_NN complexes_NNS ._. E_NNP 2_CD F_NN
        complexes_NNS activate_VBP genes_NNS required_VBN for_IN entry_NN into_IN S_NNP phase_NN ._.
        C_NNP /_NN EBPα_NNP binds_NNS to_TO and_CC inhibits_NNS transcriptional_NN activation_NN by_IN
        E_NNP 2_CD F_NN [_NN 26_CD 33_CD ]_NN ._. The_DT complex_NN of_IN E_NNP 2_CD F_NN with_IN the_DT
        retinoblastoma-related_JJ p_NN 107_CD protein_NN is_VBZ prevalent_JJ in_IN cycling_NN
        cells_NNS ._. Transcription_NNP activation_NN domain_NN 2_CD of_IN C_NNP /_NN EBPα_NNP was_VBD
        observed_VBN to_TO interact_NN specifically_RB with_IN p_NN 107_CD to_TO disrupt_VB
        p_NN 107_CD /_NN E_NNP 2_CD F_NN complex_JJ formation_NN [_NN 34_CD 35_CD ]_NN ._. Disruption_NNP of_IN E_NNP 2_CD F_NN
        activity_NN also_RB was_VBD associated_VBN the_DT basic_JJ domain_NN of_IN C_NNP /_NN EBPα_NNP [_NN
        33_CD 34_CD ]_NN ._.
        Thus_RB ,_, a_DT variety_NN of_IN interactions_NNS and_CC mechanisms_NNS are_VBP
        potentially_RB involved_VBN in_IN proliferation_NN arrest_NN by_IN C_NNP /_NN EBPα_NNP ._.
        This_DT variability_NN may_MD indicate_VB divergent_JJ mechanisms_NNS for_IN the_DT
        block_NN of_IN proliferation_NN by_IN C_NNP /_NN EBPα_NNP in_IN different_JJ study_NN
        conditions_NNS and_CC /_NN or_CC cell_NN types_NNS ._. In_IN pituitary_JJ cells_NNS ,_, C_NNP /_NN EBPα_NNP is_VBZ
        part_NN of_IN a_DT multi-subunit_JJ complex_JJ [_NN 41_CD 42_CD ]_NN that_IN activates_NNS
        the_DT growth_NN hormone_NN [_NN 42_CD ]_NN and_CC prolactin_NN [_NN 43_CD 44_CD ]_NN
        promoters_NNS ._. Full-length_NNP C_NNP /_NN EBPα_NNP is_VBZ absent_JJ from_IN the_DT pituitary_JJ
        progenitor_NN GHFT_NNP 1_CD -_: 5_CD cell_NN line_NN [_NN 42_CD 45_CD ]_NN in_IN which_WDT ectopically_RB
        expressed_VBD C_NNP /_NN EBPα_NNP activates_NNS co-transfected_JJ growth_NN hormone_NN
        and_CC prolactin_NN promoters_NNS [_NN 42_CD 44_CD 45_CD ]_NN ._. We_PRP show_VBP here_RB that_IN
        ectopically_RB expressed_VBD C_NNP /_NN EBPα_NNP prolongs_NNS GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN the_DT
        G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT cell_NN cycle_NN in_IN a_DT
        transcription-independent_JJ fashion_NN ._. Different_NNP C_NNP /_NN EBPα_NNP domains_NNS
        were_VBD required_VBN for_IN G_NNP 1_CD -_: and_CC S-_NNP phase_NN arrest_NN ._. C_NNP /_NN EBPα_NNP domains_NNS
        previously_RB described_VBD for_IN the_DT interaction_NN with_IN p_NN 21_CD were_VBD not_RB
        required_VBN for_IN arrest_NN in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ._. Rather_RB ,_, domains_NNS
        previously_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT E_NNP 2_CD F_NN and_CC CDK_NNP 2_CD
        pathways_NNS by_IN C_NNP /_NN EBPα_NNP were_VBD required_VBN for_IN arrest_NN of_IN these_DT
        progenitor_NN cells_NNS ._.
      
      
        Results_NNS
        
          Transcriptionally_NNP active_JJ and_CC inactive_JJ GFP_NNP fusions_NNS
          with_IN C_NNP /_NN EBPα_NNP
          The_DT domains_NNS of_IN C_NNP /_NN EBPα_NNP and_CC their_PRP$ known_VBN interactions_NNS
          with_IN cell-cycle_JJ proteins_NNS are_VBP summarized_VBD in_IN figure_NN 1_CD A_DT ._. We_PRP
          conducted_VBD studies_NNS to_TO determine_VB which_WDT ,_, if_IN any_DT ,_, of_IN those_DT
          activities_NNS affect_VBP the_DT proliferation_NN of_IN GHFT_NNP 1_CD -_: 5_CD pituitary_JJ
          progenitor_NN cells_NNS ._. In_IN prior_JJ studies_VBZ ,_, we_PRP noticed_VBD that_IN fewer_JJR
          cells_NNS were_VBD present_JJ in_IN GHFT_NNP 1_CD -_: 5_CD cell_NN cultures_NNS transfected_JJ
          with_IN the_DT C_NNP /_NN EBPα_NNP expression_NN vector_NN than_IN in_IN cultures_NNS
          transfected_JJ with_IN control_NN vectors_NNS (_( X_NNP ._. Wang_NNP ,_, F_NN ._. S_NNP ._. ,_,
          unpublished_JJ data_NNS )_) ._. The_DT decreased_VBN cell_NN number_NN might_MD be_VB due_JJ
          to_TO impaired_VBN proliferation_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS expressing_VBG
          C_NNP /_NN EBPα_NNP ._. To_TO examine_VB if_IN C_NNP /_NN EBPα_NNP affected_VBD the_DT progression_NN of_IN
          GHFT_NNP 1_CD -_: 5_CD cells_NNS through_IN the_DT cell_NN cycle_NN ,_, we_PRP needed_VBD to_TO
          distinguish_VB transfected_JJ cells_NNS that_WDT expressed_VBD C_NNP /_NN EBPα_NNP from_IN
          those_DT that_WDT did_VBD not_RB ._. We_PRP fused_JJ the_DT cDNA_NN for_IN the_DT green_JJ
          fluorescence_NN protein_NN (_( GFP_NNP )_) to_TO either_CC the_DT 5_CD '_POS (_( GFP-C_NNP /_NN EBPα_NNP )_)
          or_CC the_DT 3_CD '_POS (_( C_NNP /_NN EBPα-GFP_NNP )_) end_NN of_IN the_DT coding_VBG sequence_NN of_IN the_DT
          C_NNP /_NN EBPα_NNP cDNA_NN ._. The_DT cDNAs_NNS for_IN the_DT GFP-C_NNP /_NN EBPα_NNP and_CC C_NNP /_NN EBPα-GFP_NNP
          fusion_NN proteins_NNS were_VBD inserted_VBN into_IN an_DT expression_NN vector_NN
          and_CC transfected_JJ into_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ._. Flow_NNP cytometry_NN was_VBD
          used_VBN to_TO specifically_RB identify_VB green_JJ fluorescent_NN ,_,
          C_NNP /_NN EBPα-expressing_NNP cells_NNS ._.
          We_PRP initially_RB characterized_VBD the_DT abilities_NNS of_IN the_DT
          C_NNP /_NN EBPα-GFP_NNP and_CC GFP-C_NNP /_NN EBPα_NNP fusion_NN proteins_NNS to_TO bind_NN DNA_NNP and_CC
          activate_VBP transcription_NN in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS (_( Fig_NNP ._. 2_LS )_) ._. The_DT
          C_NNP /_NN EBPα-GFP_NNP or_CC GFP-C_NNP /_NN EBPα_NNP expression_NN vectors_NNS were_VBD
          transfected_JJ into_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS with_IN a_DT promoter_NN consisting_VBG
          of_IN a_DT single_JJ C_NNP /_NN EBPα_NNP binding_JJ site_NN upstream_RB of_IN the_DT growth_NN
          hormone_NN TATA_NNP box_NN ._. This_DT minimal_JJ promoter_NN was_VBD specifically_RB
          responsive_JJ to_TO C_NNP /_NN EBPα_NNP expression_NN in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS [_NN 45_CD 46_CD
          ]_NN ._. Cells_NNP transfected_JJ with_IN the_DT C_NNP /_NN EBPα-GFP_NNP expression_NN
          vector_NN showed_VBD a_DT statistically_RB significant_JJ (_( p_NN <_NN 0_CD ._. 05_CD ,_, n_NN =_SYM
          5_LS )_) 9_CD ._. 66_CD +_NN /_NN -_: 6_CD ._. 08_CD -_: fold_VB higher_JJR promoter_NN activity_NN than_IN did_VBD
          cells_NNS sham-transfected_JJ with_IN the_DT same_JJ expression_NN vector_NN
          deleted_VBN of_IN the_DT C_NNP /_NN EBPα_NNP cDNA_NN (_( Fig_NNP ._. 2_LS A_DT )_) ._. In_IN contrast_NN ,_,
          activation_NN by_IN GFP-C_NNP /_NN EBPα_NNP was_VBD a_DT statistically_RB
          insignificant_JJ 1_CD ._. 88_CD +_NN /_NN -_: 1_CD ._. 48_CD -_: fold_VB (_( Fig_NNP ._. 2_LS A_DT )_) ._. Promoter_NNP
          activation_NN by_IN C_NNP /_NN EBPα-GFP_NNP was_VBD reproducibly_RB less_JJR than_IN
          promoter_NN activation_NN by_IN unfused_JJ C_NNP /_NN EBPα_NNP ._. Western_JJ blots_NNS of_IN
          nuclear_JJ extracts_NNS from_IN the_DT transfected_JJ cells_NNS showed_VBD that_IN
          unfused_JJ C_NNP /_NN EBPα_NNP was_VBD expressed_VBN at_IN marginally_RB higher_JJR levels_NNS
          (_( Fig_NNP ._. 2_LS B_NNP )_) ._.
          C_NNP /_NN EBPα-GFP_NNP and_CC GFP-C_NNP /_NN EBPα_NNP both_DT were_VBD expressed_VBN as_IN
          intact_JJ ,_, full-length_JJ proteins_NNS of_IN the_DT appropriate_JJ molecular_JJ
          weight_NN [_NN 45_CD ]_NN (_( Fig_NNP ._. 2_LS B_NNP ,_, arrow_NN )_) ._. In_IN addition_NN ,_, both_DT
          C_NNP /_NN EBPα-GFP_NNP and_CC GFP-C_NNP /_NN EBPα_NNP bound_VBN similarly_RB to_TO DNA_NNP (_( Fig_NNP ._.
          2_LS C_NNP )_) ._. Extracts_NNP of_IN cells_NNS expressing_VBG either_CC C_NNP /_NN EBPα-GFP_NNP or_CC
          GFP-C_NNP /_NN EBPα_NNP shifted_VBD the_DT electrophoretic_JJ mobility_NN of_IN a_DT
          radiolabeled_JJ oligonucleotide_NN containing_VBG a_DT C_NNP /_NN EBPα_NNP binding_JJ
          site_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ._. No_DT shift_NN was_VBD observed_VBN with_IN
          sham-transfected_JJ cells_NNS (_( not_RB shown_VBN )_) ._. The_DT shifted_VBN bands_NNS
          were_VBD specifically_RB competed_VBN by_IN a_DT 100_CD -_: fold_VB molar_NN excess_NN of_IN
          the_DT cold_JJ oligonucleotide_NN and_CC were_VBD supershifted_JJ with_IN an_DT
          antibody_NN directed_VBN against_IN C_NNP /_NN EBPα_NNP ._. GFP-C_NNP /_NN EBPα_NNP truncated_JJ of_IN
          its_PRP$ leucine_NN zipper_NN (_( Fig_NNP ._. 1_LS B_NNP )_) was_VBD ineffective_JJ at_IN shifting_VBG
          the_DT binding_JJ site_NN (_( Fig_NNP ._. 2_LS C_NNP ,_, ΔLZ_NN )_) ._. Flow_NNP cytometry_NN
          (_( discussed_VBN later_RB )_) showed_VBD that_IN comparable_JJ levels_NNS of_IN green_JJ
          fluorescence_NN were_VBD emitted_VBN from_IN cells_NNS expressing_VBG
          C_NNP /_NN EBPα-GFP_NNP ,_, GFP-C_NNP /_NN EBPα_NNP and_CC ΔLZ_NN ._. Thus_RB ,_, C_NNP /_NN EBPα-GFP_NNP and_CC
          GFP-C_NNP /_NN EBPα_NNP were_VBD expressed_VBN and_CC could_MD bind_NN to_TO C_NNP /_NN EBPα_NNP
          binding_JJ sites_NNS in_IN DNA_NNP ,_, but_CC differed_VBD in_IN their_PRP$ ability_NN to_TO
          activate_VBP gene_NN transcription_NN ._.
        
        
          Cell_NNP cycle_NN distribution_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS
          Transcriptionally_NNP active_JJ C_NNP /_NN EBPα-GFP_NNP and_CC
          transcriptionally_RB inactive_JJ GFP-C_NNP /_NN EBPα_NNP were_VBD compared_VBN for_IN
          their_PRP$ effects_NNS on_IN proliferation_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ._. We_PRP first_RB
          determined_VBD the_DT distribution_NN of_IN untransfected_JJ GHFT_NNP 1_CD -_: 5_CD
          cells_NNS in_IN each_DT phase_NN of_IN the_DT cell_NN cycle_NN ._. GHFT_NNP 1_CD -_: 5_CD cells_NNS were_VBD
          grown_VBN to_TO subconfluence_NN ,_, collected_VBN and_CC the_DT DNA_NNP within_IN the_DT
          cells_NNS was_VBD stained_JJ with_IN propidium_NN iodide_NN ._. The_DT DNA_NNP content_NN
          within_IN each_DT cell_NN was_VBD quantified_VBN by_IN flow_NN cytometry_NN as_IN the_DT
          amount_NN of_IN orange_NN fluorescence_NN from_IN the_DT propidium_NN
          iodide-stained_JJ DNA_NNP (_( see_VB Materials_NNPS and_CC Methods_NNP for_IN
          details_NNS )_) ._. The_DT fluorescence_NN intensity_NN measured_VBN from_IN each_DT
          cell_NN falls_VBZ into_IN one_CD of_IN three_CD populations_NNS :_: cells_NNS centered_VBN
          around_IN the_DT lowest_JJS level_NN of_IN orange_NN fluorescence_NN ,_, cells_NNS
          centered_VBN around_IN the_DT highest_JJS level_NN of_IN orange_NN fluorescence_NN
          which_WDT is_VBZ twice_RB that_IN of_IN the_DT lowest_JJS ,_, and_CC cells_NNS with_IN
          intermediate_JJ levels_NNS of_IN orange_NN fluorescence_NN ._. This_DT
          corresponds_NNS ,_, respectively_RB ,_, to_TO cells_NNS containing_VBG a_DT 2_CD n_NN DNA_NNP
          complement_VB prior_RB to_TO duplication_NN of_IN the_DT genome_NN (_( in_IN G_NNP 1_CD
          phase_NN )_) ,_, cells_NNS containing_VBG a_DT 4_CD n_NN DNA_NNP complement_VB following_VBG
          genome_NN duplication_NN (_( in_IN growth_NN phase_NN 2_CD or_CC in_IN mitosis_NNS ,_,
          G_NNP 2_CD /_NN M_NNP )_) ,_, and_CC cells_NNS containing_VBG a_DT partially_RB replicated_VBN genome_NN
          intermediate_JJ between_IN 2_CD n_NN and_CC 4_CD n_NN (_( in_IN S_NNP phase_NN )_) ._. As_IN averaged_VBD
          from_IN nine_CD independent_JJ experiments_NNS ,_, the_DT proportion_NN of_IN
          growing_VBG GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN G_NNP 1_CD ,_, S_NNP and_CC G_NNP 2_CD /_NN M_NNP corresponded_VBD to_TO
          42_CD %_NN ,_, 38_CD %_NN and_CC 20_CD %_NN ,_, respectively_RB (_( Fig_NNP 3_CD ,_, white_JJ bars_NNS )_) ._.
          We_PRP next_RB synchronized_VBN GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN particular_JJ
          stages_NNS of_IN the_DT cell_NN cycle_NN ._. GHFT_NNP 1_CD -_: 5_CD cells_NNS were_VBD treated_VBN for_IN
          20_CD hours_NNS with_IN nocodazole_NN ,_, which_WDT prevents_VBZ microtubule_NN
          polymerization_NN /_NN depolymerization_NN and_CC exit_NN from_IN M_NNP phase_NN [_NN
          47_CD ]_NN ._. The_DT delivery_NN vehicle_NN ,_, DMSO_NNP ,_, was_VBD added_VBN to_TO parallel_VB
          cell_NN cultures_NNS ._. Cells_NNP also_RB were_VBD treated_VBN with_IN mimosine_NN (_( in_IN
          DMSO_NNP )_) ,_, which_WDT blocks_VBZ cells_NNS in_IN late_JJ G_NNP 1_CD immediately_RB before_IN
          entry_NN into_IN S_NNP phase_NN [_NN 48_CD ]_NN ._. Mimosine_NNP also_RB prolongs_NNS some_DT
          cell_NN types_NNS in_IN the_DT S_NNP phase_NN itself_PRP [_NN 48_CD ]_NN ._. GHFT_NNP 1_CD -_: 5_CD cells_NNS
          grow_VBP with_IN an_DT average_JJ doubling_NN time_NN of_IN approximately_RB 18_CD to_TO
          24_CD hours_NNS ._. 20_CD hours_NNS of_IN treatment_NN allowed_VBN most_JJS cells_NNS to_TO
          pass_VB through_IN one_CD cell_NN cycle_NN and_CC to_TO accumulate_VBP as_IN 4_CD n_NN cells_NNS
          upon_IN nocodazole_NN treatment_NN (_( Fig_NNP ._. 3_LS ,_, light_JJ gray_JJ bars_NNS )_) or_CC as_IN
          2_CD n_NN cells_NNS at_IN the_DT G_NNP 1_CD /_NN S_NNP boundary_NN upon_IN mimosine_NN treatment_NN
          (_( Fig_NNP ._. 3_LS ,_, stippled_JJ gray_JJ bars_NNS )_) ._. Thus_RB ,_, GHFT_NNP 1_CD -_: 5_CD cells_NNS can_MD be_VB
          synchronized_VBN at_IN particular_JJ stages_NNS of_IN the_DT cell_NN cycle_NN ._.
          Synchronization_NNP facilitated_JJ characterization_NN of_IN the_DT cell_NN
          cycle_NN stages_NNS blocked_VBN or_CC prolonged_VBN by_IN C_NNP /_NN EBPα_NNP
          expression_NN ._.
        
        
          Transcriptionally_NNP active_JJ and_CC inactive_JJ C_NNP /_NN EBPα_NNP both_DT
          retain_VB GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN the_DT G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT cell_NN
          cycle_NN
          We_PRP determined_VBD if_IN either_DT C_NNP /_NN EBPα-GFP_NNP or_CC GFP-C_NNP /_NN EBPα_NNP
          altered_VBD the_DT distribution_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN the_DT G_NNP 1_CD ,_, S_NNP or_CC
          G_NNP 2_CD /_NN M_NNP phases_NNS of_IN the_DT cell_NN cycle_NN ._. GHFT_NNP 1_CD -_: 5_CD cells_NNS were_VBD
          transfected_JJ with_IN the_DT expression_NN vectors_NNS for_IN C_NNP /_NN EBPα-GFP_NNP or_CC
          GFP-C_NNP /_NN EBPα_NNP ,_, or_CC with_IN the_DT sham_NN expression_NN vector_NN not_RB
          containing_VBG the_DT C_NNP /_NN EBPα_NNP cDNA_NN ._. The_DT cells_NNS were_VBD incubated_JJ for_IN
          one_CD day_NN to_TO allow_VB time_NN for_IN C_NNP /_NN EBPα_NNP expression_NN ._. Cells_NNP were_VBD
          then_RB synchronized_VBN in_IN M-_NNP phase_NN or_CC in_IN G_NNP 1_CD /_NN S_NNP by_IN 20_CD -_: hour_NN
          incubations_NNS with_IN nocodazole_NN (_( Fig_NNP ._. 4_LS A_DT )_) or_CC mimosine_NN (_( Fig_NNP ._.
          4_LS B_NNP )_) ._. Cells_NNP were_VBD collected_VBN and_CC stained_JJ with_IN propidium_NN
          iodide_NN ._. Flow_NNP cytometry_NN was_VBD used_VBN to_TO measure_VB DNA_NNP content_NN in_IN
          1_LS )_) cells_NNS transfected_JJ with_IN the_DT sham_NN expression_NN vector_NN
          (_( Fig_NNP ._. 4_LS ,_, Sham_NNP )_) ,_, 2_LS )_) green_JJ fluorescent_NN cells_NNS expressing_VBG
          GFP-tagged_NNP C_NNP /_NN EBPα_NNP (_( Fig_NNP ._. 4_LS ,_, C_NNP /_NN EBPα-GFP_NNP or_CC GFP-C_NNP /_NN EBPα_NNP )_) or_CC
          3_LS )_) the_DT subpopulation_NN of_IN cells_NNS from_IN the_DT C_NNP /_NN EBPα-GFP_NNP or_CC
          GFP-C_NNP /_NN EBPα_NNP transfections_NNS that_WDT did_VBD not_RB express_VB measurable_JJ
          amounts_NNS of_IN green_JJ fluorescent_NN C_NNP /_NN EBPα_NNP (_( Fig_NNP ._. 4_LS ,_, No_DT C_NNP /_NN EBP_NNP )_) ._.
          The_DT "_'' No_DT C_NNP /_NN EBP_NNP "_'' cells_NNS represent_VBP an_DT internal_JJ control_NN for_IN
          cells_NNS not_RB expressing_VBG C_NNP /_NN EBPα_NNP collected_VBD simultaneously_RB with_IN
          cells_NNS expressing_VBG C_NNP /_NN EBPα_NNP ._. The_DT No_DT C_NNP /_NN EBP_NNP controls_NNS also_RB
          indicated_VBD the_DT extent_NN to_TO which_WDT green_JJ fluorescent_NN ,_,
          C_NNP /_NN EBPα-expressing_NNP cells_NNS were_VBD distinguished_VBN from_IN
          non-expressing_JJ cells_NNS by_IN flow_NN cytometry_NN ._. For_IN all_DT our_PRP$
          experiments_NNS ,_, the_DT distribution_NN of_IN cells_NNS in_IN the_DT G_NNP 1_CD ,_, S_NNP and_CC
          G_NNP 2_CD /_NN M_NNP phases_NNS was_VBD similar_JJ for_IN the_DT "_'' No_DT C_NNP /_NN EBPα_NNP "_'' and_CC
          sham-transfected_JJ cells_NNS ._.
          The_DT expression_NN of_IN C_NNP /_NN EBPα-GFP_NNP or_CC GFP-C_NNP /_NN EBPα_NNP resulted_VBD in_IN
          a_DT statistically_RB significant_JJ decrease_NN in_IN the_DT amount_NN of_IN
          cells_NNS blocked_VBN in_IN G_NNP 2_CD /_NN M_NNP upon_IN nocodazole_NN treatment_NN compared_VBN
          to_TO sham-transfected_JJ cells_NNS (_( Fig_NNP ._. 4_LS A_DT )_) (_( p_NN <_NN <_NN 0_CD ._. 01_CD ,_, n_NN =_SYM
          6_CD )_) ._. This_DT indicated_VBD that_IN C_NNP /_NN EBPα_NNP expression_NN prevented_VBD a_DT
          significant_JJ proportion_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS from_IN reaching_VBG
          G_NNP 2_CD /_NN M_NNP to_TO be_VB blocked_VBN by_IN nocodazole_NN ._. When_WRB cells_NNS were_VBD blocked_VBN
          in_IN G_NNP 1_CD by_IN mimosine_NN treatment_NN ,_, C_NNP /_NN EBPα_NNP expression_NN caused_VBD no_DT
          decrease_NN in_IN the_DT proportion_NN of_IN cells_NNS in_IN G_NNP 2_CD /_NN M_NNP (_( Fig_NNP ._. 4_LS B_NNP )_) ._.
          This_DT demonstrated_VBN that_IN C_NNP /_NN EBPα_NNP expression_NN did_VBD not_RB actively_RB
          decrease_VB the_DT proportion_NN of_IN cells_NNS in_IN G_NNP 2_CD /_NN M_NNP ._.
          The_DT C_NNP /_NN EBPα-induced_NNP reduction_NN in_IN cells_NNS blocked_VBN in_IN G_NNP 2_CD /_NN M_NNP
          was_VBD associated_VBN with_IN a_DT highly_RB statistically_RB significant_JJ
          increase_NN in_IN the_DT proportion_NN of_IN GHFT_NNP 1_CD -_: 5_CD pituitary_JJ
          progenitor_NN cells_NNS in_IN G_NNP 1_CD (_( p_NN <_NN 0_CD ._. 001_CD )_) and_CC a_DT statistically_RB
          significant_JJ increase_NN in_IN the_DT proportion_NN of_IN cells_NNS in_IN S_NNP
          phase_NN (_( p_NN <_NN 0_CD ._. 03_CD )_) (_( Fig_NNP ._. 4_LS A_DT )_) ._. This_DT retention_NN of_IN GHFT_NNP 1_CD -_: 5_CD
          cells_NNS in_IN the_DT G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT cell_NN cycle_NN occurred_VBD
          for_IN both_DT the_DT transcriptionally_RB active_JJ C_NNP /_NN EBPα-GFP_NNP and_CC
          inactive_JJ GFP-C_NNP /_NN EBPα_NNP fusions_NNS ._. The_DT independence_NN of_IN
          C_NNP /_NN EBPα-induced_NNP proliferation_NN arrest_NN from_IN C_NNP /_NN EBPα-regulated_NNP
          transcriptional_NN activation_NN also_RB has_VBZ been_VBN observed_VBN in_IN
          other_JJ studies_NNS [_NN 25_CD 26_CD ]_NN ._. Thus_RB ,_, simple_JJ transcription_NN
          activation_NN mechanisms_NNS do_VBP not_RB account_VB for_IN the_DT effect_NN of_IN
          C_NNP /_NN EBPα_NNP on_IN the_DT cell_NN cycle_NN ._.
        
        
          Targeting_NNP of_IN C_NNP /_NN EBPα_NNP to_TO the_DT presumed_VBN centromeric_JJ
          G_NNP 1_CD /_NN S_NNP checkpoint_NN is_VBZ insufficient_JJ for_IN prolongation_NN of_IN
          G_NNP 1_CD
          Our_PRP$ prior_RB fluorescence_NN microscopy_NN studies_NNS showed_VBD that_IN
          C_NNP /_NN EBPα-GFP_NNP ,_, GFP-C_NNP /_NN EBPα_NNP ,_, and_CC antibody-stained_JJ C_NNP /_NN EBPα_NNP [_NN 45_CD
          46_CD ]_NN ,_, concentrated_VBN at_IN specific_JJ intranuclear_NN domains_NNS in_IN
          GHFT_NNP 1_CD -_: 5_CD cells_NNS (_( see_VB Fig_NNP ._. 5_LS A_DT ,_, GFP-C_NNP /_NN EBPα_NNP )_) ._. These_DT domains_NNS
          coincide_VB with_IN regions_NNS that_WDT stain_VB with_IN the_DT blue_JJ
          fluorescent_NN DNA-binding_NNP dye_NN Hoechst_NNP 33342_CD (_( Fig_NNP ._. 5_LS A_DT ,_,
          Hoechst_NNP 33342_CD )_) ._. Hoechst_NNP 33342_CD stains_NNS AT-rich_NNP DNA_NNP that_WDT
          concentrates_VBZ around_IN the_DT centromeres_NNS [_NN 45_CD 49_CD ]_NN ._. Given_VBN the_DT
          role_NN of_IN the_DT centromere_NN as_IN a_DT checkpoint_NN for_IN regulation_NN of_IN
          the_DT mitotic_JJ phase_NN of_IN the_DT cell_NN cycle_NN [_NN 50_CD 51_CD ]_NN ,_, it_PRP was_VBD
          hypothesized_VBN that_IN C_NNP /_NN EBPα_NNP localization_NN around_IN the_DT
          centromere_NN could_MD play_VB a_DT role_NN in_IN C_NNP /_NN EBPα_NNP regulation_NN of_IN the_DT
          cell_NN cycle_NN [_NN 49_CD ]_NN ._.
          To_TO investigate_VB if_IN targeting_VBG of_IN C_NNP /_NN EBPα_NNP to_TO the_DT
          peri-centromeric_JJ chromatin_NN is_VBZ necessary_JJ or_CC sufficient_JJ to_TO
          cause_VB G_NNP 1_CD and_CC S_NNP phase_NN prolongation_NN in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ,_, we_PRP
          first_RB determined_VBD the_DT domain_NN of_IN C_NNP /_NN EBPα_NNP required_VBD to_TO target_VB
          C_NNP /_NN EBPα_NNP to_TO the_DT peri-centromeric_JJ chromatin_NN ._. It_PRP was_VBD
          previously_RB suggested_VBN that_IN the_DT peri-centromeric_JJ targeting_VBG
          of_IN C_NNP /_NN EBPα_NNP was_VBD a_DT function_NN of_IN DNA_NNP binding_JJ :_: C_NNP /_NN EBPα_NNP binding_JJ
          sites_NNS are_VBP concentrated_VBN within_IN the_DT repeated_VBN DNA_NNP sequences_NNS
          that_WDT comprise_VBP the_DT bulk_NN of_IN peri-centromeric_JJ chromatin_NN [_NN 49_CD
          ]_NN ._. Indeed_RB ,_, C_NNP /_NN EBPα_NNP truncated_JJ to_TO contain_VB little_JJ more_JJR than_IN
          the_DT DNA_NNP binding_JJ ,_, bZIP_NN domain_NN still_RB concentrated_VBD at_IN
          peri-centromeric_JJ chromatin_NN [_NN 45_CD ]_NN ._. By_IN contrast_NN ,_, C_NNP /_NN EBPα_NNP
          deleted_VBN of_IN amino_JJ acids_NNS 310_CD to_TO 358_CD (_( Fig_NNP ._. 1_LS B_NNP ,_, ΔLZ_NN )_) no_RB
          longer_RB targeted_VBN to_TO the_DT peri-centromeric_JJ DNA_NNP (_( Fig_NNP ._. 5_LS B_NNP )_) ._.
          This_DT deletion_NN disrupts_NNS DNA_NNP binding_JJ (_( Fig_NNP ._. 2_LS C_NNP )_) by_IN
          eliminating_VBG the_DT leucine_NN zipper_NN required_VBN for_IN DNA_NNP binding_VBG
          by_IN all_DT members_NNS of_IN the_DT bZIP_NN family_NN of_IN transcription_NN
          factors_NNS [_NN 52_CD ]_NN ._. Thus_RB ,_, as_IN predicted_VBN [_NN 49_CD ]_NN ,_, the_DT bZIP_NN
          domain_NN is_VBZ necessary_JJ and_CC sufficient_JJ for_IN C_NNP /_NN EBPα_NNP targeting_VBG
          to_TO peri-centromeric_JJ chromatin_NN ._.
          When_WRB expressed_VBD in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ,_, ΔLZ_NN was_VBD as_RB effective_JJ
          as_IN full-length_JJ GFP-C_NNP /_NN EBPα_NNP in_IN prolonging_VBG both_DT G_NNP 1_CD and_CC S_NNP
          (_( Fig_NNP ._. 6_CD A_DT )_) ._. Thus_RB ,_, leucine_NN zipper_NN dimerization_NN ,_,
          site-specific_JJ DNA_NNP binding_JJ and_CC targeting_VBG of_IN C_NNP /_NN EBPα_NNP to_TO
          peri-centromeric_JJ were_VBD not_RB required_VBN for_IN C_NNP /_NN EBPα_NNP
          prolongation_NN in_IN G_NNP 1_CD and_CC S_NNP ._. In_IN contrast_NN ,_, the_DT isolated_VBN
          C_NNP /_NN EBPα_NNP bZIP_NN DNA_NNP binding_JJ domain_NN (_( Fig_NNP ._. 1_LS B_NNP ,_, DBD_NNP )_) ,_, which_WDT
          still_RB targeted_VBN to_TO peri-centromeric_JJ chromatin_NN ,_, did_VBD not_RB
          prolong_VB G_NNP 1_CD (_( Fig_NNP ._. 6_CD B_NNP )_) ._. S_NNP phase_NN remained_VBD prolonged_JJ upon_IN DBD_NNP
          expression_NN ._. The_DT different_JJ effects_NNS of_IN the_DT isolated_VBN DBD_NNP on_IN
          G_NNP 1_CD and_CC S_NNP blockage_NN indicated_VBD that_IN C_NNP /_NN EBPα_NNP regulation_NN of_IN G_NNP 1_CD
          and_CC S_NNP phase_NN arrest_NN was_VBD mechanistically_RB distinct_JJ ._. Thus_RB ,_,
          C_NNP /_NN EBPα_NNP regulates_VBZ proliferation_NN by_IN two_CD distinct_JJ pathways_NNS ._.
          Both_DT pathways_NNS do_VBP not_RB depend_VB upon_IN site-specific_JJ DNA_NNP
          binding_JJ ,_, which_WDT is_VBZ commonly_RB considered_VBN a_DT prerequisite_NN for_IN
          gene-specific_JJ transcription_NN ._.
        
        
          Prolongation_NNP in_IN G_NNP 1_CD requires_VBZ the_DT amino_JJ terminal_NN
          domain_NN of_IN C_NNP /_NN EBPα_NNP
          The_DT C_NNP /_NN EBPα_NNP DBD_NNP therefore_RB was_VBD insufficient_JJ for_IN
          prolongation_NN of_IN G_NNP 1_CD (_( Fig_NNP ._. 6_CD B_NNP )_) ._. We_PRP next_RB determined_VBN which_WDT
          additional_JJ domains_NNS of_IN C_NNP /_NN EBPα_NNP were_VBD required_VBN for_IN G_NNP 1_CD
          prolongation_NN ._. C_NNP /_NN EBPα_NNP amino_JJ acids_NNS 1_CD -_: 154_CD or_CC 154_CD -_: 257_CD were_VBD
          appended_VBN to_TO the_DT DBD_NNP (_( see_VB Fig_NNP ._. 1_LS B_NNP )_) ._. The_DT addition_NN of_IN amino_JJ
          acids_NNS 1_CD -_: 154_CD (_( Fig_NNP ._. 7_CD ,_, DBD_NNP +_NN 1_CD -_: 154_CD )_) caused_VBD a_DT statistically_RB
          significant_JJ increase_NN ,_, relative_JJ to_TO sham-transfected_JJ cells_NNS ,_,
          in_IN the_DT proportion_NN of_IN cells_NNS in_IN G_NNP 1_CD (_( p_NN <_NN <_NN 0_CD ._. 01_CD ,_, n_NN =_SYM
          6_CD )_) ._. The_DT proportion_NN of_IN cells_NNS in_IN G_NNP 1_CD was_VBD not_RB statistically_RB
          different_JJ in_IN cells_NNS expressing_VBG DBD_NNP +_NN 1_CD -_: 154_CD from_IN that_DT in_IN
          cells_NNS expressing_VBG full-length_JJ C_NNP /_NN EBPα-GFP_NNP ._. Adding_VBG amino_JJ
          acids_NNS 1_CD -_: 125_CD ,_, instead_RB of_IN amino_JJ acids_NNS 1_CD -_: 154_CD ,_, caused_VBD a_DT
          similar_JJ prolongation_NN in_IN G_NNP 1_CD (_( Fig_NNP ._. 7_CD ,_, DBD_NNP +_NN 1_CD -_: 125_CD )_) ._. Thus_RB ,_,
          an_DT element_NN in_IN the_DT amino_JJ terminal_NN domain_NN of_IN C_NNP /_NN EBPα_NNP was_VBD
          required_VBN for_IN G_NNP 1_CD prolongation_NN ._.
          In_IN contrast_NN ,_, addition_NN of_IN amino_JJ acids_NNS 154_CD -_: 257_CD to_TO C_NNP /_NN EBPα_NNP
          DBD_NNP did_VBD not_RB rescue_VB G_NNP 1_CD prolongation_NN (_( Fig_NNP ._. 7_CD ,_, DBD_NNP +_NN
          154_CD -_: 257_CD )_) ._. Again_RB ,_, appending_VBG amino_JJ acids_NNS 1_CD -_: 125_CD to_TO this_DT
          mutant_JJ restored_VBN G_NNP 1_CD prolongation_NN (_( A_DT 126_CD -_: 153_CD )_) ,_, as_IN did_VBD amino_JJ
          acids_NNS 1_CD -_: 97_CD (_( A_DT 98_CD -_: 153_CD )_) ._. All_DT of_IN the_DT mutants_NNS contained_VBD the_DT
          DBD_NNP and_CC prolonged_JJ the_DT cell_NN cycle_NN in_IN S_NNP phase_NN (_( Fig_NNP ._. 7_CD )_) ._.
          Thus_RB ,_, the_DT DNA_NNP binding_JJ ,_, bZIP_NN domain_NN was_VBD sufficient_JJ to_TO
          direct_VB S_NNP phase_NN regulation_NN by_IN C_NNP /_NN EBPα_NNP whereas_IN amino_JJ acids_NNS
          1_CD -_: 97_CD contained_VBD a_DT domain_NN required_VBN for_IN G_NNP 1_CD regulation_NN ._.
        
      
      
        Discussion_NNP
        
          C_NNP /_NN EBPα_NNP prolongs_NNS GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN G_NNP 1_CD and_CC S_NNP
          The_DT differentiative_JJ and_CC anti-mitotic_JJ actions_NNS of_IN C_NNP /_NN EBPα_NNP
          have_VBP been_VBN observed_VBN in_IN a_DT variety_NN of_IN cell_NN culture_NN models_NNS [_NN
          23_CD 24_CD 26_CD 40_CD 53_CD ]_NN ._. To_TO date_NN ,_, studies_NNS of_IN the_DT C_NNP /_NN EBPα_NNP block_NN
          of_IN proliferation_NN have_VBP relied_VBN on_IN comparing_VBG the_DT growth_NN [_NN 23_CD
          24_CD 25_CD 40_CD ]_NN or_CC DNA_NNP synthetic_JJ [_NN 22_CD 24_CD 25_CD 26_CD 27_CD ]_NN rates_NNS of_IN
          C_NNP /_NN EBPα-expressing_NNP and_CC non-expressing_JJ cells_NNS ._. These_DT studies_NNS
          suggest_VBP that_IN multiple_JJ ,_, possibly_RB independent_JJ ,_, mechanisms_NNS
          may_MD contribute_VB to_TO C_NNP /_NN EBPα_NNP arrest_NN in_IN a_DT variety_NN of_IN cells_NNS [_NN
          18_CD 23_CD 24_CD 25_CD 26_CD 33_CD 34_CD 35_CD 36_CD 37_CD 40_CD 54_CD 55_CD 56_CD ]_NN ._. Studies_NNPS
          that_WDT distinguish_VB the_DT anti-proliferative_JJ actions_NNS of_IN C_NNP /_NN EBPα_NNP
          at_IN different_JJ phases_NNS of_IN the_DT cell_NN cycle_NN ,_, and_CC in_IN specific_JJ
          cell_NN types_NNS ,_, may_MD clarify_VB these_DT discrepancies_NNS ._.
          Our_PRP$ studies_NNS showed_VBD that_IN C_NNP /_NN EBPα_NNP expression_NN prolonged_JJ
          the_DT proliferation_NN of_IN GHFT_NNP 1_CD -_: 5_CD pituitary_JJ progenitor_NN cells_NNS
          at_IN two_CD different_JJ phases_NNS of_IN the_DT cell_NN cycle_NN ,_, G_NNP 1_CD and_CC S_NNP (_( Fig_NNP ._.
          4_LS )_) ._. A_DT G_NNP 1_CD block_VB has_VBZ been_VBN reported_VBN previously_RB in_IN
          C_NNP /_NN EBPα-expressing_NNP mouse_NN L_NNP cells_NNS [_NN 26_CD ]_NN ._. However_RB ,_, those_DT
          studies_NNS did_VBD not_RB define_VB the_DT activities_NNS within_IN C_NNP /_NN EBPα_NNP
          required_VBD for_IN that_DT blockage_NN ._. Here_RB ,_, we_PRP observed_VBD that_DT
          prolongation_NN in_IN G_NNP 1_CD required_VBD the_DT amino_JJ terminal_NN 97_CD amino_JJ
          acids_NNS of_IN C_NNP /_NN EBPα_NNP (_( Fig_NNP ._. 7_CD ._. )_) ._. In_IN contrast_NN ,_, amino_JJ acids_NNS 1_CD to_TO
          97_CD were_VBD not_RB required_VBN for_IN S_NNP phase_NN arrest_NN (_( Figs_NNP ._. 6_CD ,_, 7_CD )_) ._.
          This_DT showed_VBD that_IN C_NNP /_NN EBPα_NNP prolongation_NN of_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN
          the_DT G_NNP 1_CD and_CC S_NNP phases_NNS occurred_VBD through_IN molecularly_RB distinct_JJ
          pathways_NNS ._. Such_JJ distinct_JJ effects_NNS on_IN G_NNP 1_CD and_CC S_NNP may_MD
          contribute_VB to_TO the_DT wide_JJ variations_NNS in_IN mechanisms_NNS reported_VBN ,_,
          to_TO date_NN ,_, to_TO participate_VB in_IN proliferation_NN arrest_NN by_IN
          C_NNP /_NN EBPα_NNP ._.
        
        
          Cell_NNP Cycle_NNP Proteins_NNPS and_CC C_NNP /_NN EBPα_NNP Inhibition_NNP of_IN
          Proliferation_NNP
          Candidate_NNP mechanisms_NNS for_IN the_DT block_NN of_IN proliferation_NN by_IN
          C_NNP /_NN EBPα_NNP include_VBP 1_LS )_) activation_NN of_IN the_DT gene_NN promoters_NNS of_IN the_DT
          cyclin-dependent_JJ kinase_NN inhibitor_NN p_NN 21_CD [_NN 37_CD ]_NN ,_, gadd_NN 45_CD [_NN 5_CD
          6_CD ]_NN ,_, gas_NN 2_CD and_CC gas_NN 3_CD [_NN 38_CD 39_CD ]_NN ,_, 2_LS )_) post-transcriptional_JJ
          stabilization_NN of_IN p_NN 21_CD [_NN 22_CD ]_NN ,_, or_CC 3_LS )_) interactions_NNS of_IN
          C_NNP /_NN EBPα_NNP with_IN cell_NN cycle_NN proteins_NNS including_VBG p_NN 21_CD [_NN 22_CD 24_CD 25_CD
          55_CD ]_NN ,_, CDK_NNP 2_CD [_NN 25_CD 36_CD ]_NN ,_, CDK_NNP 4_CD [_NN 36_CD ]_NN ,_, retinoblastoma_NN [_NN 54_CD
          ]_NN ,_, the_DT retinoblastoma-related_JJ protein_NN p_NN 107_CD [_NN 34_CD ]_NN and_CC
          the_DT G_NNP 1_CD /_NN S-_NNP regulating_VBG E_NNP 2_CD F_NN transcription_NN complex_JJ [_NN 26_CD 33_CD ]_NN
          (_( Fig_NNP ._. 1_LS A_DT )_) ._. We_PRP found_VBD that_DT transcriptional_NN activation_NN
          domain_NN 3_CD and_CC the_DT leucine_NN zipper_NN were_VBD not_RB required_VBN for_IN
          prolongation_NN of_IN either_DT G_NNP 1_CD or_CC S_NNP (_( Fig_NNP 7_CD )_) ._. These_DT domains_NNS
          interact_NN with_IN p_NN 21_CD ,_, CDK_NNP 2_CD and_CC CDK_NNP 4_CD [_NN 22_CD 24_CD 25_CD 36_CD 55_CD ]_NN ._.
          Thus_RB ,_, C_NNP /_NN EBPα_NNP interactions_NNS with_IN at_IN least_JJS p_NN 21_CD and_CC CDK_NNP 4_CD were_VBD
          not_RB required_VBN for_IN the_DT anti-proliferative_JJ actions_NNS of_IN C_NNP /_NN EBPα_NNP
          in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS ._. CDK_NNP 2_CD ,_, and_CC other_JJ proteins_NNS ,_, also_RB interact_NN
          with_IN another_DT domain_NN of_IN C_NNP /_NN EBPα_NNP [_NN 25_CD ]_NN required_VBN for_IN
          proliferation_NN arrest_NN (_( discussed_VBN below_IN )_) ._.
          Arrest_NN in_IN S_NNP phase_NN was_VBD associated_VBN with_IN amino_JJ acids_NNS 259_CD
          to_TO 310_CD (_( Fig_NNP ._. 6_CD )_) ,_, which_WDT include_VBP the_DT basic_JJ amino_JJ acid-rich_JJ ,_,
          DNA_NNP binding_JJ region_NN of_IN C_NNP /_NN EBPα_NNP ._. C_NNP /_NN EBPα_NNP deleted_VBN of_IN the_DT
          leucine_NN zipper_NN dimerization_NN domain_NN ,_, also_RB required_VBN for_IN DNA_NNP
          binding_JJ [_NN 25_CD ]_NN (_( Fig_NNP ._. 2_LS C_NNP )_) ,_, was_VBD as_RB effective_JJ as_IN full-length_JJ
          GFP-C_NNP /_NN EBPα_NNP in_IN prolonging_VBG both_DT S_NNP and_CC G_NNP 1_CD (_( Fig_NNP ._. 6_CD A_DT )_) ._. Thus_RB ,_,
          DNA_NNP binding_JJ 
          per_IN se_FW was_VBD not_RB required_VBN for_IN
          proliferation_NN arrest_NN ._. The_DT basic_JJ region_NN of_IN C_NNP /_NN EBPα_NNP blocks_VBZ
          the_DT transcriptional_NN activity_NN of_IN E_NNP 2_CD F_NN by_IN unknown_JJ mechanisms_NNS
          [_NN 33_CD ]_NN and_CC contains_VBZ another_DT known_VBN CDK_NNP 2_CD -_: interaction_NN site_NN [_NN
          25_CD ]_NN ._. Either_CC of_IN these_DT activities_NNS may_MD contribute_VB to_TO basic_JJ
          region-dependent_JJ ,_, S_NNP phase_NN arrest_NN of_IN GHFT_NNP 1_CD -_: 5_CD cell_NN
          proliferation_NN ._.
          G_NNP 1_CD block_VB in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS required_VBD C_NNP /_NN EBPα_NNP amino_JJ acids_NNS
          1_CD -_: 97_CD (_( Fig_NNP ._. 7_CD )_) ,_, comprising_VBG activation_NN domains_NNS 1_CD and_CC 2_CD [_NN 31_CD
          ]_NN ._. Amino_NNP acids_NNS 1_CD to_TO 97_CD have_VBP been_VBN implicated_VBN in_IN C_NNP /_NN EBPα_NNP
          growth_NN arrest_NN via_IN the_DT E_NNP 2_CD F_NN /_NN pl_NN 07_CD complexes_NNS [_NN 34_CD 35_CD ]_NN ._.
          C_NNP /_NN EBPα_NNP interaction_NN with_IN p_NN 107_CD is_VBZ believed_VBN to_TO prevent_VB the_DT
          formation_NN of_IN an_DT S-_NNP phase_NN promoting_VBG complex_JJ containing_VBG p_NN 107_CD
          and_CC E_NNP 2_CD F_NN [_NN 26_CD 34_CD 35_CD ]_NN ._. Thus_RB ,_, G_NNP 1_CD block_VB in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS
          may_MD be_VB related_VBN to_TO the_DT ability_NN of_IN C_NNP /_NN EBPα_NNP to_TO interact_NN with_IN
          p_NN 107_CD ._. However_RB ,_, the_DT amino_JJ terminus_JJ of_IN C_NNP /_NN EBPα_NNP also_RB
          functionally_RB interacts_NNS with_IN a_DT number_NN of_IN other_JJ factors_NNS [_NN
          31_CD 45_CD 46_CD ]_NN ,_, any_DT of_IN which_WDT might_MD contribute_VB to_TO
          proliferation_NN arrest_NN ._.
        
        
          Subnuclear_NNP Architecture_NNP and_CC C_NNP /_NN EBPα_NNP Inhibition_NNP of_IN
          Proliferation_NNP
          Tang_NNP and_CC Lane_NNP [_NN 49_CD ]_NN showed_VBD that_IN C_NNP /_NN EBPα_NNP becomes_VBZ
          associated_VBN with_IN peri-centromeric_JJ chromatin_NN upon_IN
          expression_NN during_IN adipocyte_NN differentiation_NN ._. We_PRP observed_VBD
          that_IN C_NNP /_NN EBPα_NNP ,_, expressed_VBD in_IN mouse_NN pituitary_JJ progenitor_NN
          GHFT_NNP 1_CD -_: 5_CD cells_NNS ,_, also_RB localized_VBN to_TO peri-centromeric_JJ
          chromatin_NN [_NN 45_CD ]_NN ._. Here_RB we_PRP show_VBP that_IN targeting_VBG of_IN C_NNP /_NN EBPα_NNP
          to_TO peri-centromeric_JJ chromatin_NN in_IN GHFT_NNP 1_CD -_: 5_CD cells_NNS required_VBD
          the_DT DNA_NNP binding_JJ domain_NN of_IN C_NNP /_NN EBPα_NNP (_( Fig_NNP ._. 5_LS )_) ._. However_RB ,_,
          C_NNP /_NN EBPα_NNP deleted_VBN of_IN the_DT DNA_NNP binding_JJ domain_NN was_VBD as_RB effective_JJ
          as_IN full-length_JJ C_NNP /_NN EBPα_NNP in_IN prolonging_VBG GHFT_NNP 1_CD -_: 5_CD cells_NNS in_IN the_DT
          G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT cell_NN cycle_NN (_( Fig_NNP ._. 6_CD A_DT )_) ._. Thus_RB ,_, the_DT
          specific_JJ association_NN of_IN C_NNP /_NN EBPα_NNP with_IN peri-centromeric_JJ
          chromatin_NN ,_, speculated_VBD to_TO contribute_VB to_TO C_NNP /_NN EBPα_NNP growth_NN
          arrest_NN [_NN 49_CD ]_NN ,_, was_VBD not_RB necessary_JJ for_IN disruption_NN of_IN the_DT
          cell_NN cycle_NN by_IN C_NNP /_NN EBPα_NNP ._. The_DT independence_NN of_IN C_NNP /_NN EBPα_NNP
          regulation_NN of_IN proliferation_NN from_IN its_PRP$ intranuclear_NN
          localization_NN may_MD even_RB be_VB necessary_JJ since_IN we_PRP have_VBP recently_RB
          determined_VBN that_IN pituitary_JJ cell_NN differentiation_NN is_VBZ
          associated_VBN with_IN the_DT dispersal_NN of_IN C_NNP /_NN EBPα_NNP from_IN
          peri-centromeric_JJ heterochromatin_NN by_IN the_DT
          pituitary-specific_JJ transcription_NN factor_NN Pit-_NNP 1_CD (_( J_NNP ._. F_NN ._. E_NNP ._. ,_,
          M_NNP ._. A_DT ._. Kawecki_NNP ,_, F_NN ._. S_NNP ._. ,_, R_NN ._. N_NNP ._. D_NNP ._. ,_, submitted_VBN )_) ._.
        
        
          Transcription-_NNP Independent_NNP Inhibition_NNP of_IN
          Proliferation_NNP
          Transcription_NNP factors_NNS ,_, like_IN C_NNP /_NN EBPα_NNP ,_, may_MD regulate_VB cell_NN
          proliferation_NN by_IN directly_RB controlling_VBG the_DT expression_NN of_IN
          proteins_NNS required_VBN for_IN cell_NN cycle_NN progression_NN ._. Indeed_RB ,_,
          C_NNP /_NN EBPα_NNP activates_NNS transcription_NN of_IN the_DT p_NN 21_CD [_NN 37_CD ]_NN ,_, gadd_NN 45_CD
          [_NN 5_CD 6_CD ]_NN ,_, gas_NN 2_CD and_CC gas_NN 3_CD [_NN 38_CD 39_CD ]_NN genes_NNS ._. However_RB ,_, similar_JJ
          levels_NNS of_IN p_NN 21_CD mRNA_NN in_IN the_DT livers_NNS of_IN wild-type_JJ and_CC
          homozygous_JJ C_NNP /_NN EBPα_NNP knock-out_JJ mice_NNS [_NN 22_CD ]_NN argue_VBP against_IN a_DT
          physiologically_RB significant_JJ contribution_NN of_IN C_NNP /_NN EBPα_NNP to_TO p_NN 21_CD
          gene_NN transcription_NN in_IN the_DT liver_NN ._. We_PRP also_RB observed_VBD that_IN
          transcriptionally_RB inactive_JJ and_CC DNA-binding-defective_NNP
          forms_NNS of_IN C_NNP /_NN EBPα_NNP still_RB blocked_VBD GHFT_NNP 1_CD -_: 5_CD cell_NN proliferation_NN
          in_IN both_DT the_DT G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT cell_NN cycle_NN (_( Figs_NNP ._. 2_LS ,_,
          4_CD ,_, 6_CD )_) ._. DNA-binding-defective_NNP mutants_NNS of_IN C_NNP /_NN EBPα_NNP have_VBP also_RB
          been_VBN observed_VBN to_TO block_VB proliferation_NN in_IN other_JJ cell_NN lines_NNS
          [_NN 25_CD 33_CD ]_NN ._. Together_RB ,_, this_DT suggests_VBZ that_IN C_NNP /_NN EBPα_NNP
          regulation_NN of_IN transcription_NN ,_, in_IN general_JJ ,_, might_MD not_RB
          contribute_VB to_TO the_DT regulation_NN of_IN cell_NN proliferation_NN ._. It_PRP
          remains_VBZ possible_JJ that_IN C_NNP /_NN EBPα_NNP activation_NN of_IN the_DT
          transcription_NN of_IN some_DT cell_NN cycle_NN regulatory_JJ genes_NNS does_VBZ
          control_NN proliferation_NN in_IN some_DT cell_NN types_NNS or_CC under_IN certain_JJ
          conditions_NNS [_NN 8_CD 37_CD 38_CD 39_CD 56_CD ]_NN ._.
          The_DT absence_NN of_IN a_DT dependence_NN of_IN GHFT_NNP 1_CD -_: 5_CD cell_NN
          proliferation_NN on_IN transcription_NN factor_NN activities_NNS that_WDT are_VBP
          more_RBR classically_RB associated_VBN with_IN transcription_NN regulation_NN
          strongly_RB suggests_VBZ that_IN C_NNP /_NN EBPα_NNP ,_, and_CC perhaps_RB other_JJ
          transcription_NN factors_NNS ,_, control_NN proliferation_NN and_CC
          transcription_NN through_IN completely_RB separable_JJ pathways_NNS ._. The_DT
          effects_NNS of_IN human_JJ papilloma_NN virus_NN E_NNP 7_CD proteins_NNS on_IN
          C_NNP /_NN EBPα-induced_NNP differentiation_NN and_CC growth_NN arrest_NN also_RB
          suggest_VBP that_IN the_DT effects_NNS of_IN C_NNP /_NN EBPα_NNP on_IN proliferation_NN are_VBP
          mechanistically_RB divergent_JJ [_NN 40_CD ]_NN ._. Having_VBG distinct_JJ
          mechanisms_NNS for_IN regulation_NN of_IN gene_NN transcription_NN and_CC
          proliferation_NN allows_VBZ a_DT transcription_NN factor_NN to_TO regulate_VB
          these_DT two_CD critical_JJ processes_VBZ completely_RB independently_RB of_IN
          one_CD another_DT ._. This_DT may_MD be_VB particularly_RB important_JJ in_IN
          differentiated_JJ ,_, non-proliferating_JJ cells_NNS in_IN which_WDT events_NNS
          that_WDT regulate_VB a_DT transcription_NN factor_NN 's_POS contribution_NN to_TO
          gene_NN expression_NN must_MD be_VB disconnected_VBN from_IN that_DT
          transcription_NN factor_NN 's_POS continuing_VBG blockage_NN of_IN
          proliferation_NN ._.
        
      
      
        Conclusions_NNP
        C_NNP /_NN EBPα_NNP is_VBZ a_DT transcription_NN factor_NN that_IN controls_NNS both_DT
        proliferation_NN and_CC gene_NN expression_NN ._. C_NNP /_NN EBPα_NNP uses_VBZ molecularly_RB
        distinct_JJ mechanisms_NNS to_TO prolong_VB the_DT G_NNP 1_CD and_CC S_NNP phases_NNS of_IN
        pituitary_JJ progenitor_NN GHFT_NNP 1_CD -_: 5_CD cells_NNS ._. The_DT anti-proliferative_JJ
        effects_NNS of_IN C_NNP /_NN EBPα_NNP do_VBP not_RB require_VB activities_NNS in_IN C_NNP /_NN EBPα_NNP
        commonly_RB required_VBD for_IN gene-specific_JJ transcription_NN ._.
        Proliferation_NNP arrest_NN instead_RB corresponds_NNS with_IN C_NNP /_NN EBPα_NNP
        domains_NNS previously_RB implicated_VBN in_IN post-transcriptional_JJ
        effects_NNS on_IN E_NNP 2_CD F_NN and_CC /_NN or_CC CDK_NNP 2_CD activity_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Plasmid_NNP construction_NN
          The_DT GFP-C_NNP /_NN EBPα_NNP vector_NN was_VBD constructed_VBN by_IN inserting_VBG the_DT
          cDNA_NN encoding_VBG the_DT S_NNP 65_CD T_NN derivative_NN of_IN GFP_NNP [_NN 57_CD ]_NN at_IN the_DT
          start_NN codon_NN of_IN the_DT cDNA_NN encoding_VBG rat_NN C_NNP /_NN EBPα_NNP ._. The_DT fused_JJ
          cDNA_NN was_VBD cloned_VBN into_IN a_DT previously_RB described_VBN expression_NN
          vector_NN [_NN 58_CD ]_NN ._. The_DT GFP_NNP and_CC C_NNP /_NN EBPα_NNP portions_NNS of_IN the_DT fusion_NN
          were_VBD separated_VBN by_IN a_DT 16_CD amino_JJ acid_NN long_JJ linker_NN including_VBG
          the_DT epitope_NN for_IN the_DT FLAG_NNP antibody_NN ._. The_DT C_NNP /_NN EBPα-GFP_NNP vector_NN
          was_VBD constructed_VBN by_IN inserting_VBG the_DT S_NNP 65_CD T_NN GFP_NNP into_IN the_DT NcoI_NNP
          site_NN present_JJ near_IN the_DT carboxy_NN terminus_JJ of_IN rat_NN C_NNP /_NN EBPα_NNP
          (_( also_RB tagged_VBN at_IN the_DT amino_JJ terminus_JJ with_IN the_DT FLAG_NNP epitope_NN )_)
          in_IN our_PRP$ previously_RB described_VBD C_NNP /_NN EBPα_NNP expression_NN vector_NN [_NN 42_CD
          ]_NN ._. This_DT resulted_VBD in_IN a_DT deletion_NN of_IN the_DT last_JJ four_CD amino_JJ
          acids_NNS of_IN C_NNP /_NN EBPα_NNP ._. The_DT DBD_NNP and_CC DBD_NNP +_NN 154_CD -_: 257_CD derivatives_NNS of_IN
          C_NNP /_NN EBPα_NNP were_VBD constructed_VBN by_IN replacing_VBG ,_, respectively_RB ,_, the_DT
          amino_JJ terminal_NN 257_CD amino_JJ acids_NNS of_IN C_NNP /_NN EBPα-GFP_NNP (_( to_TO the_DT
          SgrAI_NNP site_NN of_IN C_NNP /_NN EBPα_NNP )_) and_CC the_DT amino_JJ terminal_NN 153_CD amino_JJ
          acids_NNS of_IN C_NNP /_NN EBPα-GFP_NNP (_( to_TO the_DT NotI_NNP site_NN of_IN C_NNP /_NN EBPα_NNP )_) with_IN
          oligonucleotides_NNS containing_VBG a_DT strong_JJ Kozak_NNP sequence_NN ._. DBD_NNP
          +_NN 1_CD -_: 154_CD was_VBD constructed_VBN by_IN replacing_VBG amino_JJ acids_NNS 155_CD to_TO
          257_CD (_( from_IN the_DT NotI_NNP to_TO SgrAI_NNP sites_NNS )_) with_IN an_DT
          oligonucleotide_NN ._. The_DT remaining_VBG constructs_NNS (_( Fig_NNP ._. 7_CD )_) were_VBD
          generated_VBN by_IN appending_VBG C_NNP /_NN EBPα_NNP fragments_NNS to_TO the_DT NotI_NNP site_NN
          of_IN DBD_NNP +_NN 1_CD -_: 154_CD ,_, or_CC to_TO the_DT SgrAI_NNP site_NN of_IN DBD_NNP ._. ΔLZ_NN was_VBD
          constructed_VBN by_IN deleting_VBG amino_JJ acids_NNS from_IN amino_JJ acid_NN 310_CD
          (_( Tth_NNP 111_CD II_NNP site_NN )_) at_IN the_DT junction_NN of_IN the_DT basic_JJ region_NN and_CC
          leucine_NN zipper_NN of_IN C_NNP /_NN EBPα_NNP to_TO the_DT carboxy_NN terminus_JJ of_IN the_DT
          GFP-C_NNP /_NN EBPα_NNP fusion_NN ._. The_DT C_NNP /_NN EBP-TATA_NNP reporter_NN used_VBN to_TO
          determine_VB the_DT transcriptional_NN activity_NN of_IN the_DT two_CD GFP_NNP
          fusion_NN proteins_NNS was_VBD previously_RB described_VBN [_NN 45_CD ]_NN ._.
        
        
          Transfection_NNP
          GHFT_NNP 1_CD -_: 5_CD cells_NNS were_VBD propagated_JJ at_IN 37_CD °_NN C_NNP and_CC 5_CD %_NN CO_NNP 
          2_CD in_IN Dulbecco_NNP 's_POS modified_VBN Eagle_NNP
          (_( DME-H_NNP 21_CD )_) medium_NN supplemented_JJ with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ._.
          Approximately_RB 1_CD ×_NN 10_CD 7_CD cells_NNS were_VBD transfected_JJ by_IN
          electroporation_NN ,_, as_RB previously_RB described_VBD [_NN 42_CD ]_NN ,_, with_IN 5_CD
          μg_NN of_IN either_DT the_DT C_NNP /_NN EBPα-GFP_NNP ,_, GFP-C_NNP /_NN EBPα_NNP ,_, or_CC control_NN
          expression_NN vectors_NNS ._. Following_VBG transfection_NN ,_, cells_NNS were_VBD
          propagated_JJ at_IN 33_CD °_NN C_NNP ._. Incubation_NNP at_IN 33_CD °_NN C_NNP results_NNS in_IN
          significantly_RB higher_JJR levels_NNS of_IN green_JJ fluorescence_NN
          (_( unpublished_JJ data_NNS )_) ,_, presumably_RB because_IN of_IN better_JJR folding_NN
          of_IN the_DT jellyfish_NN GFP_NNP ._. Transfected_NNP cells_NNS were_VBD maintained_VBN
          in_IN the_DT dark_NN throughout_IN the_DT experiment_NN to_TO minimize_VB
          fluorescence_NN activation_NN of_IN GFP_NNP prior_RB to_TO flow_VB
          cytometry_NN ._.
        
        
          DNA_NNP Binding_NNP and_CC Promoter_NNP Activation_NNP
          Electrophoretic_NNP mobility_NN shifts_VBZ assays_NNS were_VBD done_VBN by_IN
          mixing_VBG a_DT radiolabeled_JJ oligonucleotide_NN containing_VBG a_DT
          consensus_NN ,_, high_JJ affinity_NN C_NNP /_NN EBP_NNP binding_JJ site_NN
          (_( GATCGAGCCCCATTGCGCAATCATAGATC_NNP )_) together_RB with_IN extracts_NNS
          prepared_VBN from_IN transfected_JJ cells_NNS as_RB previously_RB described_VBD [_NN
          58_CD 59_CD ]_NN ._. Competition_NN with_IN the_DT same_JJ ,_, unlabeled_JJ
          oligonucleotide_NN in_IN 1_CD ,_, 10_CD or_CC 100_CD molar_NN excess_NN of_IN the_DT
          radiolabeled_JJ probed_JJ indicated_VBD specific_JJ binding_JJ ._. The_DT
          protein_NN DNA_NNP complex_NN was_VBD supershifted_JJ with_IN an_DT antibody_NN
          directed_VBN against_IN C_NNP /_NN EBPα_NNP (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_,
          sc-_NN 61_CD )_) ._. For_IN studies_NNS of_IN the_DT transcriptional_NN activation_NN
          properties_NNS of_IN the_DT fusion_NN proteins_NNS ,_, 1_CD μg_NN of_IN the_DT C_NNP /_NN EBP-TATA_NNP
          vector_NN [_NN 45_CD ]_NN was_VBD co-transfected_JJ and_CC transcriptional_NN
          activity_NN was_VBD assessed_VBN by_IN measuring_VBG the_DT amount_NN of_IN
          chloramphenicol_NN acetyltransferase_NN reporter_NN expressed_VBD with_IN
          and_CC without_IN C_NNP /_NN EBPα_NNP expression_NN [_NN 45_CD ]_NN ._.
        
        
          Fluorescence_NNP Microscopy_NNP
          Following_VBG transfection_NN ,_, most_JJS cells_NNS were_VBD plated_JJ into_IN 14_CD
          cm_NN dishes_NNS and_CC allowed_VBN to_TO grow_VB for_IN 24_CD hours_NNS ._. This_DT ensured_JJ
          that_IN the_DT cells_NNS were_VBD not_RB confluent_NN by_IN the_DT time_NN of_IN
          collection_NN for_IN cell_NN cycle_NN analysis_NN ._. A_DT small_JJ portion_NN of_IN
          the_DT transfected_JJ cells_NNS were_VBD cultivated_VBN on_IN a_DT 22_CD ×_NN 22_CD mm_NN No_UH ._.
          1_LS borosilicate_NN glass_NN cover_NN slip_VB in_IN a_DT separate_JJ 6_CD -_: well_RB dish_NN
          and_CC treated_VBN with_IN nocodazole_NN ,_, mimosine_NN or_CC vehicle_NN alone_RB as_IN
          described_VBN below_IN ._. The_DT coverslips_NNS were_VBD removed_VBN for_IN
          fluorescence_NN microscopic_JJ observation_NN immediately_RB before_IN
          collecting_VBG cells_NNS for_IN flow_NN cytometric_JJ analysis_NN of_IN DNA_NNP
          content_NN and_CC GFP_NNP expression_NN ._. Cells_NNP were_VBD stained_JJ 10_CD -_: 20_CD
          minutes_NNS with_IN 5_CD μg_NN /_NN ml_NN of_IN the_DT cell-permeable_JJ DNA_NNP binding_JJ
          dye_NN Hoechst_NNP 33342_CD ._. The_DT green_JJ fluorescence_NN emitted_VBN from_IN
          C_NNP /_NN EBPα_NNP tagged_VBN with_IN GFP_NNP and_CC the_DT blue_JJ fluorescence_NN emitted_VBN
          from_IN Hoechst_NNP 33342_CD -_: stained_JJ DNA_NNP were_VBD readily_RB distinguished_VBN
          by_IN selectively_RB exciting_JJ each_DT fluorophore_NN and_CC capturing_VBG
          fluorescence_NN emissions_NNS specific_JJ for_IN each_DT fluorophore_NN
          using_VBG appropriate_JJ excitation_NN and_CC emission_NN filter_NN sets_NNS
          (_( Chroma_NNP Technology_NNP Corporation_NNP ,_, Brattelboro_NNP ,_, VT_NNP )_) [_NN 45_CD ]_NN ._.
          The_DT images_NNS shown_VBN in_IN Fig_NNP ._. 5_LS were_VBD acquired_VBN using_VBG an_DT Olympus_NNP
          40_CD X_NNP PlanApochromat_NNP (_( 0_CD ._. 95_CD numerical_JJ aperture_NN )_) objective_NN on_IN
          an_DT Olympus_NNP IX-_NNP 70_CD microscope_NN ._. Metamorph_NNP acquisition_NN
          software_NN (_( Universal_NNP Imaging_NNP Corporation_NNP ,_, Downingtown_NNP ,_, PA_NNP )_)
          on_IN an_DT Orca_NNP cooled_VBD interline_NN camera_NN (_( Hamamatsu_NNP ,_,
          Bridgewater_NNP ,_, NJ_NNP )_) were_VBD used_VBN to_TO collect_VB the_DT images_NNS ._.
        
        
          Post-transfection_NNP Cell_NNP Synchronization_NNP
          The_DT C_NNP /_NN EBPα_NNP fusion_NN proteins_NNS were_VBD expressed_VBN for_IN one_CD day_NN
          following_VBG transfection_NN ,_, after_IN which_WDT we_PRP added_VBD to_TO the_DT cell_NN
          culture_NN media_NNS 100_CD ng_NN /_NN ml_NN nocodazole_NN (_( Sigma_NNP )_) in_IN
          dimethylsulphoxide_NN (_( DMSO_NNP )_) ,_, 0_CD ._. 5_CD mM_NN mimosine_NN (_( Sigma_NNP )_) in_IN
          DMSO_NNP ,_, or_CC DMSO_NNP vehicle_NN ._. In_IN some_DT experiments_NNS ,_, cells_NNS were_VBD
          also_RB grown_VBN for_IN 48_CD and_CC 72_CD hours_NNS post-transfection_JJ before_IN
          applying_VBG nocodazole_NN (_( data_NNS not_RB shown_VBN )_) ._. The_DT distributions_NNS
          of_IN cells_NNS in_IN G_NNP 1_CD ,_, S_NNP and_CC G_NNP 2_CD /_NN M_NNP ,_, in_IN the_DT presence_NN or_CC absence_NN of_IN
          C_NNP /_NN EBPα_NNP expression_NN ,_, were_VBD similar_JJ for_IN cells_NNS grown_VBN for_IN 24_CD
          (_( reported_VBD here_RB )_) ,_, 48_CD or_CC 72_CD hours_NNS (_( data_NNS not_RB shown_VBN )_) prior_RB to_TO
          nocodazole_NN addition_NN ._. Following_VBG nocodazole_NN ,_, mimosine_NN or_CC
          DMSO_NNP addition_NN ,_, the_DT transfected_JJ GHFT_NNP 1_CD -_: 5_CD cells_NNS continued_VBD to_TO
          be_VB cultivated_VBN at_IN 33_CD °_NN C_NNP ._.
        
        
          Flow_NNP Cytometry_NNP
          24_CD hours_NNS after_IN drug_NN or_CC vehicle_NN treatment_NN ,_, transfected_JJ
          cells_NNS were_VBD trypsinized_JJ ,_, collected_VBN in_IN DME-H_NNP 21_CD media_NNS
          containing_VBG 10_CD %_NN fetal_JJ calf_NN serum_NN ,_, and_CC washed_VBD twice_RB with_IN
          PBS_NNP ._. The_DT harvested_VBN cells_NNS (_( typically_RB 5_CD ×_NN 10_CD 6_CD to_TO 1_CD ×_NN 10_CD
          7_CD cells_NNS )_) were_VBD resuspended_JJ in_IN 300_CD μl_NN of_IN 8_CD μg_NN /_NN ml_NN propidium_NN
          iodide_NN (_( Molecular_NNP Probes_NNP )_) in_IN PBS_NNP containing_VBG 0_CD ._. 1_CD %_NN NP-_NNP 40_CD
          and_CC 10_CD μg_NN /_NN ml_NN RNAse_NNP A_DT ,_, then_RB incubated_JJ at_IN room_NN temperature_NN
          in_IN the_DT dark_NN for_IN 30_CD minutes_NNS ._. The_DT cell_NN suspension_NN was_VBD then_RB
          analyzed_VBN on_IN a_DT FACScan_NNP flow_NN cytometer_NN (_( Becton_NNP Dickinson_NNP )_)
          at_IN a_DT flow_NN rate_NN of_IN 12_CD μl_NN /_NN min_NN ._. Fluorescence_NNP of_IN the_DT GFP_NNP and_CC
          propidium_NN iodide-bound_JJ DNA_NNP was_VBD excited_VBN with_IN a_DT 488_CD nm_NN
          argon-ion_JJ laser_NN ._. Green_NNP GFP_NNP fluorescence_NN was_VBD collected_VBN
          using_VBG a_DT 530_CD /_NN 30_CD -_: nm_NN band_NN pass_NN filter_NN ,_, and_CC orange_NN emission_NN
          from_IN propidium_NN iodide-bound_JJ DNA_NNP was_VBD detected_VBN using_VBG a_DT
          585_CD /_NN 42_CD -_: nm_NN band_NN pass_NN filter_NN ._. Photomultiplier_NNP tube_NN voltage_NN
          and_CC spectral_NN compensation_NN were_VBD initially_RB set_VBN using_VBG
          single-stained_JJ cells_NNS (_( cells_NNS expressing_VBG GFP_NNP fusions_NNS with_IN
          C_NNP /_NN EBPα_NNP but_CC not_RB stained_JJ with_IN propidium_NN iodide_NN and_CC cells_NNS
          transfected_JJ with_IN the_DT control_NN vector_NN containing_VBG no_DT GFP_NNP
          cDNA_NN but_CC stained_JJ with_IN propidium_NN iodide_NN )_) ._. Electronic_JJ
          compensation_NN was_VBD adjusted_VBN among_IN the_DT fluorescence_NN channels_NNS
          to_TO remove_VB residual_JJ spectral_NN overlap_VB ._. The_DT area_NN and_CC width_NN
          of_IN each_DT event_NN were_VBD measured_VBN to_TO discriminate_JJ intact_JJ single_JJ
          cells_NNS from_IN debris_NN and_CC from_IN doublet_NN or_CC multiple_JJ cells_NNS
          stuck_VBN together_RB ._. GFP_NNP fluorescence_NN and_CC propidium_NN
          iodide-stained_JJ DNA_NNP fluorescence_NN was_VBD thus_RB collected_VBN from_IN
          single_JJ cells_NNS ._. A_DT minimum_NN of_IN 10_CD ,_, 000_CD cellular_JJ events_NNS was_VBD
          collected_VBN for_IN each_DT sample_NN ._. Data_NNP was_VBD analyzed_VBN using_VBG
          CELLQuest_NNP software_NN (_( Becton_NNP Dickenson_NNP )_) ,_, and_CC cell_NN cycle_NN
          subset_NN analyses_NNS of_IN DNA_NNP histograms_NNS were_VBD performed_VBN using_VBG
          ModFitLT_NNP ™_NN software_NN (_( Verity_NNP Software_NNP House_NNP ,_, Topsham_NNP ,_,
          ME_NNP )_) ._.
        
        
          Statistical_NNP Analysis_NNP
          One-way_NNP analysis_NN of_IN variance_NN was_VBD used_VBN to_TO compare_VB data_NNS
          from_IN multiple_JJ independent_JJ experiments_NNS ._. Statistically_NNP
          significant_JJ differences_NNS (_( *_NN *_NN ,_, p_NN <_NN 0_CD ._. 01_CD ;_: *_NN ,_, p_NN <_NN 0_CD ._. 05_CD
          compared_VBN to_TO the_DT Sham-transfected_NNP cells_NNS )_) and_CC experiment_NN
          number_NN are_VBP indicated_VBN in_IN the_DT figures_NNS and_CC legends_NNS ._. All_DT
          significant_JJ differences_NNS were_VBD confirmed_VBN by_IN paired_VBN ,_,
          one-tailed_JJ t-tests_JJ ._.
        
      

      
        List_NN of_IN abbreviations_NNS
        C_NNP /_NN EBPα_NNP CCAAT_NNP /_NN Enhancer_NNP Binding_NNP Protein_NNP alpha_NN
        G_NNP 1_CD Growth_NN phase_NN 1_CD of_IN the_DT cell_NN cycle_NN
        S_NNP DNA_NNP Synthesis_NNP phase_NN of_IN the_DT cell_NN cycle_NN
        G_NNP 2_CD Growth_NN phase_NN 2_CD of_IN the_DT cell_NN cycle_NN
        M_NNP Mitsosis_NNP phase_NN of_IN the_DT cell_NN cycle_NN
        CDK_NNP Cyclin-_NNP Dependent_NNP Kinase_NNP
        GFP_NNP Green_NNP Fluorescent_NNP Protein_NNP
        GFP-C_NNP /_NN EBPα_NNP Fusion_NNP protein_NN with_IN GFP_NNP attached_VBD to_TO the_DT amino_JJ
        terminus_JJ of_IN C_NNP /_NN EBPα_NNP
        C_NNP /_NN EBPα-GFP_NNP Fusion_NNP protein_NN with_IN GFP_NNP attached_VBD to_TO the_DT
        carboxy_NN terminus_JJ of_IN C_NNP /_NN EBPα_NNP
        Δ_NN Symbol_NN signifying_VBG "_'' deletion_NN "_'' when_WRB naming_VBG
        constructs_NNS
        LZ_NNP Leucine_NNP Zipper_NNP
        DBD_NNP DNA_NNP Binding_NNP Domain_NNP
        DMSO_NNP Dimethyl_NNP Sulfoxide_NNP
      
    
  
